• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Planet health

    The climate emergency is turning fragile supply chains into a crisis

    Disasters are increasingly putting the shaky global supply chain for medicines in the spotlight. But what can be done to fix it?

    By Andrew Green // 15 March 2023

    Even before catastrophic floods hit Pakistan last year, antiretroviral medicines, or ARV, were in short supply for people in the country living with HIV. Some patients were traveling up to seven hours to receive care and pick up free medicines at government clinics. When the floods began in June, facilities already stretched by the COVID-19 pandemic started to run out of lifesaving medications altogether, said Anmol Mohan, a recent medical school graduate who began investigating after ARV shortages were reported during the pandemic.

    “Patients didn’t have lifesaving medicines,” she said. “People had to travel, to take the whole day off and then the medicines weren’t there.”

    The private market became the only source for such medicines, she said, but at prices that were out of reach of many patients. That left people in danger of developing resistance to the treatment and of falling dangerously ill.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    Read more:

    ► Climate change's toll on global health increasingly getting attention

    ► Humanitarian system not designed to withstand climate change, WFP says

    ► Inside USAID's $150 billion strategy to fight climate change (Pro)

    • Global Health
    • Private Sector
    • Trade & Policy
    • JSI
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Andrew Green

      Andrew Green@_andrew_green

      Andrew Green, a 2025 Alicia Patterson Fellow, works as a contributing reporter for Devex from Berlin.

    Search for articles

    Related Stories

    Global healthNew partnerships aim to fix Africa's broken medical supply chains

    New partnerships aim to fix Africa's broken medical supply chains

    Global healthHow Asia-Pacific can boost vaccine access in the next pandemic

    How Asia-Pacific can boost vaccine access in the next pandemic

    Global healthOpinion: Trump aid shock underscores need for more made-in-Africa medicine

    Opinion: Trump aid shock underscores need for more made-in-Africa medicine

    Global healthHow economic resilience projects are helping HIV patients survive aid cuts

    How economic resilience projects are helping HIV patients survive aid cuts

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 4
      How is China's foreign aid changing?
    • 5
      2024 US foreign affairs funding bill a 'slow-motion gut punch'
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement